Stock Report

Download full stock data and analysis for free Last Updated: 25-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Lasa Supergenerics Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: LASA | BSE: 540702

₹4.91

up-down-arrow ₹-0.25 (-4.84%)

As on 19-Oct-2026IST

Market cap

info icon

₹27 Cr

Revenue (TTM)

info icon

₹6 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 1,029.55 -93.87 -95.17 -63.55 -48.98
EBIT 13.71 -42.71 -100.70 -57.59 -190.01
Net Profit 16.16 -67.63 -156.18 -5.35 -196.92
EPS 14.08 83.05 50.06 14.86 -194.10
Book Value -- -- -18.27 -20.96 -15.97
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-24Mar-23
EBIT-Margin info -7.480.12-224.58-8.10-15.45
Net Margin info -18.03-8.13-253.90-20.81-29.39
Return on equity info -17.18-6.69-29.40-20.22-27.97
Return on Capital info -13.53-3.33---13.23-23.94
Return on Assets info -12.36-5.03-19.73-13.81-20.71
Debt to Equity (x) info ----0.000.230.18

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
--
-13.23
-23.94
-3.41
17.14
Peer Median
--
16.46
15.49
17.37
17.62
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-29.40

Lower than Peers by 37.86

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
-29.40
-20.22
-27.97
-3.37
15.17
Peer Median
8.46
13.87
14.72
15.70
18.36
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-19.73

Lower than Peers by 26.81

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
-19.73
-13.81
-20.71
-2.56
10.43
Peer Median
7.08
8.04
7.19
9.43
9.43
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-224.58

Lower than Peers by 233.52

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
-224.58
-8.10
-15.45
1.10
15.51
Peer Median
8.94
10.05
10.28
13.90
17.27
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-253.90

Lower than Peers by 262.13

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
-253.90
-20.81
-29.39
-3.88
11.25
Peer Median
8.24
9.11
6.78
10.91
12.99
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
0.00
-10.60
-19.45
6.69
19.07
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-95.17

Lower than Peers by 100.39

Year on year growth in net sales

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
-95.17
-19.47
-5.51
-32.24
21.00
Peer Median
5.21
7.17
10.56
12.63
15.47
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-100.70

Lower than Peers by 98.23

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
-100.70
57.79
-1,428.98
-95.20
148.53
Peer Median
-2.48
12.05
6.17
-2.90
51.73
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-156.18

Lower than Peers by 160.83

Year on year growth in profit after tax

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
-156.18
43.73
-624.41
-123.41
527.76
Peer Median
4.65
22.15
27.97
-14.10
44.15
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

50.06

Higher than Peers by 51.27

Year on year growth in earnings per share

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
50.06
43.73
-624.42
-119.00
527.75
Peer Median
-1.21
8.80
--
-3.68
38.52
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
--
-18.27
-25.08
-0.65
12.34
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
--
0.23
0.18
0.13
0.12
Peer Median
0.02
0.03
0.05
0.14
0.23
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.62

Lower than Peers by 1.78

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
0.62
0.78
0.92
1.48
1.59
Peer Median
2.40
2.20
1.93
1.82
1.75
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.51

Lower than Peers by 1.19

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
0.51
0.39
0.59
1.22
1.16
Peer Median
1.71
1.72
1.59
1.30
1.04
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-30.16

Lower than Peers by 39.54

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
-30.16
-8.60
-9.09
-93.74
15.28
Peer Median
9.38
12.28
12.45
16.98
15.07
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

0.65

Lower than Peers by 25.82

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
0.65
3.44
1.91
13.53
7.30
Peer Median
26.46
26.23
23.97
24.57
20.26
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.08

Lower than Peers by 0.63

Sales / Average Total Assets

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
0.08
0.66
0.69
0.66
0.93
Peer Median
0.70
0.74
0.88
0.82
0.79
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
--
10.61
29.63
44.35
31.94
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
--
57.63
35.78
38.27
39.28
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
--
56.97
45.30
59.24
75.46
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
--
11.27
20.11
23.39
-4.24
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
--
--
--
--
10.70
Peer Median
48.06
39.17
40.74
25.97
33.71
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.58

Lower than Peers by 3.44

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
0.58
1.14
0.78
1.32
1.53
Peer Median
4.02
3.61
3.87
2.79
4.36
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
--
--
--
0.60
0.42
Peer Median
0.12
0.19
0.20
0.65
0.28
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-4.39

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
-4.39
56.20
-23.51
13.00
5.46
Peer Median
--
28.79
25.41
15.07
23.32
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

27

Lower than Peers by 4,770

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Lasa Supergenerics
27
110
93
209
244
Peer Median
4,796
3,944
2,959
3,742
6,050
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...